◆英語タイトル:AroCell AB (AROC) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9389
◆発行会社(調査会社):
GlobalData
◆発行日:2018年11月
◆ページ数:26
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Summary
AroCell AB (AroCell), formerly Xi Bao Research AB, is a drug development company that develops and commercializes tests used for the prognosis and monitoring of treatment of cancer. The company develops TK 210 ELISA kits for measuring the enzyme TK1 which is a protein that is elevated in the blood when there is increased cell turnover (cell growth and cell death) within the patient. Its TK 210 ELISA kits provide the tests for studying cellular proliferation, tumor cell turnover, and therapy response. AroCell is headquartered in Uppsala, Sweden.
AroCell AB (AROC) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.
Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AroCell AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AroCell AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AroCell AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AroCell AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AroCell AB, Medical Devices Deals, 2012 to YTD 2018 9
AroCell AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AroCell AB, Pharmaceuticals & Healthcare, Deal Details 11
Partnerships 11
AroCell Enters into Co-Development Agreement with Green Cross Cell 11
AroCell Enters Into Agreement With GenScript To Develop New Antibodies 12
Equity Offering 13
AroCell Completes Rights Offering Of Units For US$1.3 Million 13
AroCell AB – Key Competitors 14
AroCell AB – Key Employees 15
AroCell AB – Locations And Subsidiaries 16
Head Office 16
Recent Developments 17
Financial Announcements 17
Mar 08, 2018: TG Therapeutics, Inc. Announces Fourth Quarter and Year-End 2017 Financial Results and Business Update 17
Nov 22, 2017: AroCell : Reporting period 1 July – 30 September 2017 19
Aug 24, 2017: AroCell: Interim report, Q2 2017 20
Feb 16, 2017: AroCell: (publ) Year-End Report 22
Corporate Communications 24
Aug 30, 2018: AroCell appoints Anders Hultman as its new CFO 24
Government and Public Interest 25
Aug 24, 2018: New publication from AroCell demonstrating the value of Thymidine Kinase 1 as a tumor biomarker 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26
List of Tables
AroCell AB, Pharmaceuticals & Healthcare, Key Facts, 2017 2
AroCell AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AroCell AB, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AroCell AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AroCell AB, Deals By Therapy Area, 2012 to YTD 2018 8
AroCell AB, Medical Devices Deals, 2012 to YTD 2018 9
AroCell AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
AroCell Enters into Co-Development Agreement with Green Cross Cell 11
AroCell Enters Into Agreement With GenScript To Develop New Antibodies 12
AroCell Completes Rights Offering Of Units For US$1.3 Million 13
AroCell AB, Key Competitors 14
AroCell AB, Key Employees 15
List of Figures
AroCell AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AroCell AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AroCell AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AroCell AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AroCell AB, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AroCell AB, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AroCell AB, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AroCell AB, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AroCell AB, Medical Devices Deals, 2012 to YTD 2018 9